Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

3(75%)

Results Posted

100%(1 trials)

Phase Distribution

Ph not_applicable

25%

Ph phase_2

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

3(75.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(1)

Detailed Status

Recruiting2

Completed1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 23 (75.0%)

N/A1 (25.0%)

Trials by Status

completed125%

recruiting250%

active_not_recruiting125%

Recent Activity

3 active trials

Showing 4 of 4

recruitingphase_2

Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease

NCT04902703

recruitingnot_applicable

The Effect of Hyaluronic Acid Injection on TNF-Alpha and IL-1β in Knee Osteoarthritis

NCT06960564

active_not_recruitingphase_2

A Comparative Study on the Impact of Trigger Points Injection of Platelet Rich Plasma Versus Botulinum Toxin on the Relief of Jaw Muscles Myofascial Pain

NCT06814535

completedphase_2

Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease

NCT01409915

Clinical Trials (4)

Showing 4 of 4 trials

NCT04902703Phase 2

Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease

Recruiting

NCT06960564Not Applicable

The Effect of Hyaluronic Acid Injection on TNF-Alpha and IL-1β in Knee Osteoarthritis

Recruiting

NCT06814535Phase 2

A Comparative Study on the Impact of Trigger Points Injection of Platelet Rich Plasma Versus Botulinum Toxin on the Relief of Jaw Muscles Myofascial Pain

Active Not Recruiting

NCT01409915Phase 2

Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4